SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Elllk who wrote (1462)2/3/1997 6:09:00 AM
From: Richard Mazzarella   of 4342
 
Larry, thanks for the information, I had thought wrongly that they had done an in vivo.

Paul, I think that it's unrealistic to get scientific feedback from uncontrolled tests of people that will try a number of things all at the same time. I hope the products don't take on the aspect of "magic" and used as a substitute for drugs that could really help them. I am not saying that AndroVir will not help them, but the lower cost and fewer side effects could have people shift from a therapy that would be more useful in the long term to AndroVir. Considering this potential, I would have to assume that PRLN people would not let that market condition occur. I must conclude that AndroVir must be considered superior to current therapy when use with anything else. I must misunderstand the AndroVir potential because I thought the true superior potential for AIDS was PRLN herbal extracts in a cocktail that John described in his phone conference. Comments?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News